Open Access

[Corrigendum] Hepa1‑6‑FLuc cell line with the stable expression of firefly luciferase retains its primary properties with promising bioluminescence imaging ability

  • Authors:
    • Yasha Li
    • Mengnan Liu
    • Jiejie Cui
    • Ke Yang
    • Li Zhao
    • Mengjia Gong
    • Yi Wang
    • Yun He
    • Tongchuan He
    • Yang Bi
  • View Affiliations

  • Published online on: March 27, 2023     https://doi.org/10.3892/ol.2023.13773
  • Article Number: 187
  • Copyright : © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

May-2023
Volume 25 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li Y, Liu M, Cui J, Yang K, Zhao L, Gong M, Wang Y, He Y, He T, Bi Y, Bi Y, et al: [Corrigendum] Hepa1‑6‑FLuc cell line with the stable expression of firefly luciferase retains its primary properties with promising bioluminescence imaging ability. Oncol Lett 25: 187, 2023
APA
Li, Y., Liu, M., Cui, J., Yang, K., Zhao, L., Gong, M. ... Bi, Y. (2023). [Corrigendum] Hepa1‑6‑FLuc cell line with the stable expression of firefly luciferase retains its primary properties with promising bioluminescence imaging ability. Oncology Letters, 25, 187. https://doi.org/10.3892/ol.2023.13773
MLA
Li, Y., Liu, M., Cui, J., Yang, K., Zhao, L., Gong, M., Wang, Y., He, Y., He, T., Bi, Y."[Corrigendum] Hepa1‑6‑FLuc cell line with the stable expression of firefly luciferase retains its primary properties with promising bioluminescence imaging ability". Oncology Letters 25.5 (2023): 187.
Chicago
Li, Y., Liu, M., Cui, J., Yang, K., Zhao, L., Gong, M., Wang, Y., He, Y., He, T., Bi, Y."[Corrigendum] Hepa1‑6‑FLuc cell line with the stable expression of firefly luciferase retains its primary properties with promising bioluminescence imaging ability". Oncology Letters 25, no. 5 (2023): 187. https://doi.org/10.3892/ol.2023.13773